-
2023
-
ChemDiv and Insilico Medicine Form A Strategic Alliance to Develop Oncology Focused Libraries Using Artificial Intelligence
-
New molecule may help fight obesity
-
Viriom Announces Collaboration with NIH on Zika and Other Major Viral Diseases
-
NewVac Reports Primary Endpoint Met in Phase II Clinical Trial of Quisinostat in Platinum-Resistant Ovarian Cancer
-
Regen BioPharma Begins Optimization of NR2F6 Small Molecule Modulators
-
ChemDiv поможет Afraxis усовершенствовать платформу синаптического профилирования для открытия лекарств для ЦНС
-
ChemDiv Achieves Milestone in Viriom Collaboration on Elsulfavirine/VM1500A Long Acting Injectable Formulation Development
-
Nature Communications Publishes a Study that Identified Small Molecule Which Imposes Metabolic Stress and Cellular Death in Malignant Cells
-
Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS
-
ChemDiv, DZNE and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration